High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome

Ovarian cancer (OC) is the most lethal gynecological malignancy, with platinum‐based chemotherapy remaining the mainstay for adjuvant treatment after surgery. The lack of indication for immunotherapy may at least in part result from the lack of suitable biomarkers allowing stratification of potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Dominik, Fiegl, Heidi, Zeimet, Alain G., Wieser, Verena, Marth, Christian, Sprung, Susanne, Sopper, Sieghart, Hartmann, Gunther, Reimer, Daniel, Boesch, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Tumor Immunology and Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028124/
https://www.ncbi.nlm.nih.gov/pubmed/31800094
http://dx.doi.org/10.1002/ijc.32818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028124/
https://www.ncbi.nlm.nih.gov/pubmed/31800094
http://dx.doi.org/10.1002/ijc.32818

Ejemplares similares